Foods & Inns Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 9, 2025, 1:11 am

Competitors of Foods & Inns Ltd

All Competitor Stocks of Foods & Inns Ltd

Quarterly Result

Last Updated: August 19, 2025, 3:35 pm

Below is a detailed analysis of the quarterly data for Foods & Inns Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 236.15 Cr.. The value appears to be declining and may need further review. It has decreased from 397.33 Cr. (Mar 2025) to 236.15 Cr., marking a decrease of 161.18 Cr..
• For Expenses, as of Jun 2025, the value is 211.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 349.59 Cr. (Mar 2025) to 211.79 Cr., marking a decrease of 137.80 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.36 Cr.. The value appears to be declining and may need further review. It has decreased from 47.74 Cr. (Mar 2025) to 24.36 Cr., marking a decrease of 23.38 Cr..
• For OPM %, as of Jun 2025, the value is 10.32%. The value appears to be declining and may need further review. It has decreased from 12.02% (Mar 2025) to 10.32%, marking a decrease of 1.70%.
• For Other Income, as of Jun 2025, the value is 3.07 Cr.. The value appears strong and on an upward trend. It has increased from 2.78 Cr. (Mar 2025) to 3.07 Cr., marking an increase of 0.29 Cr..
• For Interest, as of Jun 2025, the value is 11.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.42 Cr. (Mar 2025) to 11.70 Cr., marking a decrease of 3.72 Cr..
• For Depreciation, as of Jun 2025, the value is 5.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.39 Cr. (Mar 2025) to 5.67 Cr., marking an increase of 0.28 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.06 Cr.. The value appears to be declining and may need further review. It has decreased from 29.71 Cr. (Mar 2025) to 10.06 Cr., marking a decrease of 19.65 Cr..
• For Tax %, as of Jun 2025, the value is 29.42%. The value appears to be increasing, which may not be favorable. It has increased from 22.82% (Mar 2025) to 29.42%, marking an increase of 6.60%.
• For Net Profit, as of Jun 2025, the value is 7.10 Cr.. The value appears to be declining and may need further review. It has decreased from 22.93 Cr. (Mar 2025) to 7.10 Cr., marking a decrease of 15.83 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.97. The value appears to be declining and may need further review. It has decreased from 3.12 (Mar 2025) to 0.97, marking a decrease of 2.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:26 pm

Growth

Last Updated: September 5, 2025, 3:30 pm

Balance Sheet

Last Updated: July 25, 2025, 1:17 pm

Below is a detailed analysis of the balance sheet data for Foods & Inns Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 532.00 Cr.. The value appears strong and on an upward trend. It has increased from 393.00 Cr. (Mar 2024) to 532.00 Cr., marking an increase of 139.00 Cr..
• For Borrowings, as of Mar 2025, the value is 440.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 469.00 Cr. (Mar 2024) to 440.00 Cr., marking a decrease of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 311.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 160.00 Cr. (Mar 2024) to 311.00 Cr., marking an increase of 151.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,290.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,027.00 Cr. (Mar 2024) to 1,290.00 Cr., marking an increase of 263.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 327.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Mar 2024) to 327.00 Cr., marking an increase of 81.00 Cr..
• For CWIP, as of Mar 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2024) to 11.00 Cr., marking a decrease of 28.00 Cr..
• For Investments, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 948.00 Cr.. The value appears strong and on an upward trend. It has increased from 729.00 Cr. (Mar 2024) to 948.00 Cr., marking an increase of 219.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,290.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,027.00 Cr. (Mar 2024) to 1,290.00 Cr., marking an increase of 263.00 Cr..

Notably, the Reserves (532.00 Cr.) exceed the Borrowings (440.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Foods & Inns Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 5.92. This value is within the healthy range. It has decreased from 6.82 (Mar 24) to 5.92, marking a decrease of 0.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 5.91. This value is within the healthy range. It has decreased from 6.16 (Mar 24) to 5.91, marking a decrease of 0.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has decreased from 9.38 (Mar 24) to 8.56, marking a decrease of 0.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.43. It has increased from 69.99 (Mar 24) to 73.43, marking an increase of 3.44.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.43. It has increased from 69.99 (Mar 24) to 73.43, marking an increase of 3.44.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 135.13. It has decreased from 179.71 (Mar 24) to 135.13, marking a decrease of 44.58.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.55. This value is within the healthy range. It has decreased from 22.38 (Mar 24) to 17.55, marking a decrease of 4.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.73. This value is within the healthy range. It has decreased from 19.49 (Mar 24) to 14.73, marking a decrease of 4.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 6.81. This value is within the healthy range. It has decreased from 11.37 (Mar 24) to 6.81, marking a decrease of 4.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 5.74. This value is within the healthy range. It has decreased from 6.49 (Mar 24) to 5.74, marking a decrease of 0.75.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.71. This value is within the healthy range. It has decreased from 6.47 (Mar 24) to 5.71, marking a decrease of 0.76.
• For PBDIT Margin (%), as of Mar 25, the value is 12.98. This value is within the healthy range. It has increased from 12.45 (Mar 24) to 12.98, marking an increase of 0.53.
• For PBIT Margin (%), as of Mar 25, the value is 10.89. This value is within the healthy range. It has increased from 10.84 (Mar 24) to 10.89, marking an increase of 0.05.
• For PBT Margin (%), as of Mar 25, the value is 5.03. This value is below the healthy minimum of 10. It has decreased from 6.32 (Mar 24) to 5.03, marking a decrease of 1.29.
• For Net Profit Margin (%), as of Mar 25, the value is 4.24. This value is below the healthy minimum of 5. It has increased from 3.61 (Mar 24) to 4.24, marking an increase of 0.63.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 8. It has increased from 3.59 (Mar 24) to 4.22, marking an increase of 0.63.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.77. This value is below the healthy minimum of 15. It has decreased from 9.24 (Mar 24) to 7.77, marking a decrease of 1.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.29. This value is within the healthy range. It has decreased from 22.44 (Mar 24) to 17.29, marking a decrease of 5.15.
• For Return On Assets (%), as of Mar 25, the value is 3.24. This value is below the healthy minimum of 5. It has decreased from 3.57 (Mar 24) to 3.24, marking a decrease of 0.33.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 24) to 0.12, marking a decrease of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.79. This value is within the healthy range. It has decreased from 1.18 (Mar 24) to 0.79, marking a decrease of 0.39.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.11 (Mar 24) to 0.85, marking a decrease of 0.26.
• For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.35 (Mar 24) to 1.40, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.62 (Mar 24) to 0.65, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 4. It has decreased from 2.11 (Mar 24) to 1.73, marking a decrease of 0.38.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.29 (Mar 24) to 0.00, marking a decrease of 7.29.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.04 (Mar 24) to 0.00, marking a decrease of 5.04.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.71 (Mar 24) to 0.00, marking a decrease of 92.71.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.96 (Mar 24) to 0.00, marking a decrease of 94.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.22. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to 2.22, marking a decrease of 0.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.72. This value is below the healthy minimum of 3. It has decreased from 1.80 (Mar 24) to 1.72, marking a decrease of 0.08.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,021.75. It has decreased from 1,167.36 (Mar 24) to 1,021.75, marking a decrease of 145.61.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.03, marking a decrease of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 7.93. This value is within the healthy range. It has decreased from 9.19 (Mar 24) to 7.93, marking a decrease of 1.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.60, marking a decrease of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 92.70 (Mar 24) to 0.00, marking a decrease of 92.70.
• For Price / BV (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.12, marking a decrease of 0.74.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.72 (Mar 24) to 0.60, marking a decrease of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness